Anthony M. Brade, Ph.D.
Affiliations: | 2002 | University of Toronto, Toronto, ON, Canada |
Area:
Medical Biophysics, Molecular BiologyGoogle:
"Anthony Brade"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Fei-Fei Lin | grad student | 2002 | University of Toronto | |
| (Heat-directed cancer gene therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ko JJ, Banerji S, Blais N, et al. (2023) Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current Oncology (Toronto, Ont.). 30: 3817-3828 |
| Louie AV, Granton PV, Fairchild A, et al. (2022) Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial. Jama Oncology |
| Brade A, Jao K, Yu S, et al. (2021) A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer. Current Oncology (Toronto, Ont.). 28: 1618-1629 |
| Robinson DAG, Snow S, Brade A, et al. (2020) Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations. Cancer Treatment and Research Communications. 25: 100265 |
| Melosky B, Cheema PK, Brade A, et al. (2020) Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer. The Oncologist |
| Louie A, Granton P, Fairchild A, et al. (2020) 51: A Phase Iii Randomized Trial of Palliative Radiation for Advanced Central Lung Tumours with Intentional Avoidance of the Esophagus (Proactive) Radiotherapy and Oncology. 150: S25-S26 |
| Louie A, Granton P, Bezjak A, et al. (2020) A Phase III Randomized Trial of Palliative Radiation for Advanced Central Lung Tumors with Intentional Avoidance of the Esophagus (PROACTIVE) International Journal of Radiation Oncology*Biology*Physics. 108: S105-S106 |
| Melosky B, Juergens R, McLeod D, et al. (2019) Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 134: 259-267 |
| Cheema PK, Rothenstein J, Melosky B, et al. (2019) Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer. Current Oncology (Toronto, Ont.). 26: 37-42 |
| Schuffenegger PM, Barry AS, Atenafu E, et al. (2019) Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma with Macrovascular Invasion International Journal of Radiation Oncology Biology Physics. 105 |